Cargando…

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study

BACKGROUND: Hemodialysis (HD) patients are commonly prescribed phosphate binders (PBs) to manage serum phosphorus levels, as hyperphosphatemia is strongly associated with poorer survival. Nonadherence with the PB prescription is associated with elevated serum phosphorus levels. We studied associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCullough, Keith, Port, Friedrich K, de Sequera, Patricia, Rayner, Hugh, Pecoits-Filho, Roberto, Walpen, Sebastian, Evenepoel, Pieter, Pisoni, Ronald L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323136/ https://www.ncbi.nlm.nih.gov/pubmed/34345411 http://dx.doi.org/10.1093/ckj/sfab098

Ejemplares similares

Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS
por: Lopes, Marcelo Barreto, et al.
Publicado: (2020)

Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009)

Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
por: Gray, Kathryn, et al.
Publicado: (2019)

Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS
por: Port, Friedrich K., et al.
Publicado: (2017)

Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Phosphate binders in dialysis: better satisfied than sorry
por: Cozzolino, Mario, et al.
Publicado: (2021)

Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study
por: Kanda, Eiichiro, et al.
Publicado: (2020)

Survival Among Incident Peritoneal Dialysis Versus Hemodialysis Patients Who Initiate With an Arteriovenous Fistula
por: Mukhopadhyay, Purna, et al.
Publicado: (2020)

Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2023)

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014)

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
por: Akizawa, Tadao, et al.
Publicado: (2021)

Hemoglobin A(1c) Levels and Mortality in the Diabetic Hemodialysis Population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Ramirez, Sylvia Paz B., et al.
Publicado: (2012)

Interventional study to improve adherence to phosphate binder treatment in dialysis patients
por: Hjemås, Bodil Jahren, et al.
Publicado: (2019)

Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Robinson, Bruce M., et al.
Publicado: (2017)

World-wide, mortality is a high risk soon after initiation of hemodialysis
por: Robinson, Bruce, et al.
Publicado: (2013)

Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019–21)
por: Gan, Liangying, et al.
Publicado: (2022)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2015)

Mortality risk in patients on hemodiafiltration versus hemodialysis: a ‘real-world’ comparison from the DOPPS
por: Locatelli, Francesco, et al.
Publicado: (2018)

Factors Affecting Hemodialysis Patients' Satisfaction with Their Dialysis Therapy
por: Al Eissa, M., et al.
Publicado: (2010)

Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
por: Martins, Maria Tereza Silveira, et al.
Publicado: (2013)

Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients
por: Hashimoto, Hiroko, et al.
Publicado: (2021)

International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study
por: Chan, Kevin, et al.
Publicado: (2019)

Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients
por: Sukul, Nidhi, et al.
Publicado: (2020)

Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
por: Tanaka, Akihito, et al.
Publicado: (2023)

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
por: Egli-Spichtig, Daniela, et al.
Publicado: (2023)

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey
por: Aylward, Ryan, et al.
Publicado: (2021)

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis
por: Kendrick, Jessica, et al.
Publicado: (2019)

Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies
por: Wang, Lin-Chun, et al.
Publicado: (2021)

Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients
por: Karaboyas, Angelo, et al.
Publicado: (2020)

Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Hecking, Manfred, et al.
Publicado: (2014)

Peritoneal dialysis modality transition and impact on phosphate and potassium serum levels
por: Peruzzo, Daniela, et al.
Publicado: (2021)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature
por: Cataldo, Emanuela, et al.
Publicado: (2018)

Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
por: Thiem, Ursula, et al.
Publicado: (2022)

Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
por: Lim, Eunsoo, et al.
Publicado: (2018)

Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
por: Nadin, Carole
Publicado: (2005)

The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients
por: D’Alessandro, Claudia, et al.
Publicado: (2015)

Routinely measured cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide as predictors of mortality in haemodialysis patients
por: Eriguchi, Masahiro, et al.
Publicado: (2022)

High rates of death and hospitalization follow bone fracture among hemodialysis patients
por: Tentori, Francesca, et al.
Publicado: (2013)

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Yamamoto, Suguru, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c844ll6pa8ghog1duar5r2vbvm